Xabier Elcoroaristizabal Martín-rekin lankidetzan egindako argitalpenak (12)

2014

  1. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4

2013

  1. Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ε4 carriers: A case-control study

    BMJ Open, Vol. 3, Núm. 9

  2. The Expanded mtDNA Phylogeny of the Franco-Cantabrian Region Upholds the Pre-Neolithic Genetic Substrate of Basques

    PLoS ONE, Vol. 8, Núm. 7

2012

  1. UBQ-8i polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer's disease in APOE-4 carriers

    Current Alzheimer Research, Vol. 9, Núm. 4, pp. 467-472

2011

  1. Análisis genéticos de polimorfismos en los genes CYP46A1, OGG1, CYP17A1 y CYP1A1 en pacientes con deterioro cognitivo leve tipo amnésico (aDCL) y enfermedad de Alzheimer (EA) portadores del alelo APOE 4r

    Antropo, Vol. 24, pp. 31-42

  2. Mitochondrial DNA analysis of formalin-fixed paraffin-embedded tissue samples: Effect of formalin on DNA stability and its implications in genetic studies

    Forensic Science International: Genetics Supplement Series, Vol. 3, Núm. 1

  3. Nueva propuesta metodológica para la estimación de la eficiencia energética de la Cadena de Transporte de Electrones mitocondrial en linfocitos T CD4+

    Antropo, Vol. 25, pp. 1-9

  4. Papel de la genética en la etiología de las sinucleinopatías

    Revista Espanola de Geriatria y Gerontologia, Vol. 46, Núm. SUPPL. 1, pp. 3-11

  5. Perfiles genéticos de longevidad y envejecimiento saludable en nonagenarios del país vasco

    Revista Espanola de Geriatria y Gerontologia, Vol. 46, Núm. 4, pp. 217-222

  6. Progression from amnesic mild cognitive impairment to alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene

    Dementia and Geriatric Cognitive Disorders, Vol. 32, Núm. 5, pp. 332-341

2010

  1. Quality standards in Biobanking: Authentication by genetic profiling of blood spots from donor's original sample

    European Journal of Human Genetics, Vol. 18, Núm. 7, pp. 848-851

2009

  1. The COMT Val158 met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

    BMC Neuroscience, Vol. 10, pp. 125